1. A randomized, double‐blind, placebo‐controlled, dose‐finding trial with Lolium perenne peptide immunotherapy. Issue 4 (22nd December 2017) Authors: Mösges, R.; Kasche, E. M.; Raskopf, E.; Singh, J.; Sohlich, L.; Astvatsatourov, A.; Shah‐Hosseini, K.; Pirotton, S.; Haazen, L.; Durham, S. R.; Legon, T.; Zadoyan, G.; Shamji, M. H. Journal: Allergy Issue: Volume 73:Issue 4(2018) Page Start: 896 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗